OVERVIEW

Oncology is entering a pivotal decade, one fueled by innovations that change the very foundation of how cancer is understood, detected and treated. Personalized cancer vaccines, next-generation cell therapies, precision gene editing, AI-driven diagnostic intelligence, radiotheranostics and microbiome-modulated therapies are accelerating a shift from reactive treatment to proactive, biology-driven intervention. Together, these breakthroughs are redefining the future of global cancer care.

Amid this rapid evolution, 2026 marks a landmark moment: a significant return to in-person global oncology dialogue following COVID, ushering a new era of collective scientific progress. As the world reconnects, the need for unified interpretation, responsible translation of evidence and shared global strategy has never been more essential.

The Global Conclave in Oncology 2026 is not simply a conference, it is the international meeting point where clinicians, researchers, educators and innovators converge to shape the next decade of cancer care. It is where precision medicine moves from promise to daily practice, where the world’s leading thinkers debate emerging paradigms and where you become part of the transformation redefining outcomes for patients everywhere.

Prof. Timothy Price (SA Health) has been instrumental in guiding and advising GCO Conference 2026, bringing his global expertise and strategic insight to shape a scientifically robust and internationally relevant program.